AlanaAdeleKennedy-NasserMD

Clinical Trials

• Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant Start of enrollment: 2004 Apr 01

  Completed

  Phase 1

• Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD Start of enrollment: 2007 Jun 01

  Completed

  Phase 2

• T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE Start of enrollment: 2007 Oct 01

  Terminated

  Not Applicable

• T-Reg Cell Kinetics, Stem Cell Transplant, REGALE Start of enrollment: 2007 Oct 01

  Terminated

  Not Applicable

• CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene Start of enrollment: 2008 Dec 01

  Active, not recruiting

  Phase 1

• Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) Start of enrollment: 2008 Nov 01

  Completed

  Phase 1, Phase 2

• Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT Start of enrollment: 2009 Apr 01

  Active, not recruiting

  Phase 1

• Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus Start of enrollment: 2009 May 01

  Completed

  Phase 1

• Join now to see all